RECOVERY trial investigates baricitinib as potential COVID-19 treatment, NIHR
The NIHR-supported RECOVERY trial has begun investigating the anti-inflammatory arthritis drug, baricitinib, as a potential treatment for hospitalised COVID-19 patients.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
More News: Arthritis | COVID-19 | Health | National Institute for Health Research (NIHR) | Rheumatology